In this study, spray-dried formulations differing in morphology (spherical and wrinkled), surface polarity (hydrophilic and hydrophobic), and size (20-30 µm and 3 µm) were evaluated in a nasal cast to assess their deposition profiles. The objective was to identify how formulation properties and application aspects influence the deposition profile. For this purpose, the formulations were administered at different application angles (45° and 60°), fill weights (20 mg and 40 mg), and airflow rates (0 L/min and 15 L/min) in conjunction with a UDS powder device. The results indicate a more posterior deposition profile for 45° compared to 60° due to increased deposition in the turbinate region; conversely, deposition profiles between fill weights were comparable. Application with simultaneous airflow should be avoided because of an increasing postnasal fraction. No influence of morphology could be observed, but for the surface polarity an influence was apparent, if the powder was applied with a simulated inspiration. In these cases, a hydrophobic formulation was better dispersible than a hydrophilic formulation, which led to an increased postnasal fraction. A particle size for pulmonary application demonstrated comparable results to nasal formulations with respect to the turbinate deposition but exhibited a high postnasal fraction for hydrophobic formulations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejpb.2025.114666 | DOI Listing |
Eur J Pharm Biopharm
April 2025
Department of Pharmaceutics and Biopharmaceutics, Kiel University, 24118 Kiel, Germany; Priority Research Area Kiel Nano, Surface and Interface Sciences (KiNSIS), Kiel University, Kiel, Germany. Electronic address:
In this study, spray-dried formulations differing in morphology (spherical and wrinkled), surface polarity (hydrophilic and hydrophobic), and size (20-30 µm and 3 µm) were evaluated in a nasal cast to assess their deposition profiles. The objective was to identify how formulation properties and application aspects influence the deposition profile. For this purpose, the formulations were administered at different application angles (45° and 60°), fill weights (20 mg and 40 mg), and airflow rates (0 L/min and 15 L/min) in conjunction with a UDS powder device.
View Article and Find Full Text PDFInt J Pharm
July 2023
CICS-UBI - Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal; Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal. Electronic address:
Perampanel (PER) is a potent third-generation antiepileptic drug only available for oral administration. Additionally, PER has shown potential in managing epilepsy comorbidities such as anxiety. Previously, we demonstrated that the intranasal (IN) administration of PER, loaded in a self-microemulsifying drug delivery system (SMEDDS), improved brain-targeting and exposure in mice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!